Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CETP | P11597 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | UBE2N | P61088 | 1/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL572638 | 1.00 | GPR84 (0.48) | GPR84SPHK1FFAR1EPHX1CYP2D6 | |
| SCHEMBL6577262 | 1.00 | GPR84 (0.48) | GPR84SPHK1FFAR1EPHX1CYP2D6 | |
| SCHEMBL5151362 | 1.00 | GPR84 (0.48) | GPR84SPHK1FFAR1EPHX1CYP2D6 | |
| SCHEMBL1299745 | 1.00 | GPR84 (0.48) | GPR84SPHK1FFAR1EPHX1CYP2D6 | |
| Propylene Glycol SCHEMBL4654734 | 0.93 | CYP2D6 (0.49) | GPR84SPHK1FFAR1EPHX1CYP2D6 | |
| SCHEMBL11340264 | 0.90 | FAAH (0.54) | FFAR1GMNNLMNAPOLBBLM | |
| SCHEMBL10538672 | 0.90 | FAAH (0.54) | FFAR1GMNNLMNAPOLBBLM | |
| SCHEMBL15329288 | 0.87 | MAPT (0.54) | GPR84FFAR1EPHX1MAPTGRIK1 | |
| SCHEMBL5145791 | 0.86 | KDM4E (0.58) | FFAR1LMNAKDM4ETP53CYP1A2 | |
| SCHEMBL7183545 | 0.86 | EPHX1 (0.48) | GPR84SPHK1FFAR1EPHX1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 371 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116407481-B | Skin care composition, bath foam and preparation method thereof | 芜湖美的智能厨电制造有限公司 | 2024-09-03 | — | — | CN | claimed |
| CN-118217215-A | Water emulsion mixed cream and preparation method thereof | 广州梵之容化妆品有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-221061795-U | Separation and purification integrated device of cetyl-PG hydroxyethyl palmitamide | 江苏健而晟生物科技有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-117838562-A | Skin-soothing and repairing composition and preparation method and application thereof | 花安堂生物科技集团有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-117462444-A | Multiple ceramide essence | 深圳市护家科技有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-117462442-A | Use of ceramide compositions for skin anti-aging | 深圳市护家科技有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-117384058-A | Synthesis method of cetyl-PG hydroxyethyl palmitoamide | 青岛三人行化学有限公司 | 2024-01-12 | — | — | CN | claimed |
| CN-116807936-A | Skin care product combining nitric oxide precursor and polypeptide | 中迪泰克(南京)生物科技有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-116570530-A | Cosmetic with high ceramide content and preparation method thereof | 广州环亚化妆品科技股份有限公司 | 2023-08-11 | — | — | CN | claimed |
| CN-115363982-B | Modified silicon powder prepared by supergravity acceleration process and application thereof | 广州花出见生物科技有限公司 | 2023-07-25 | — | — | CN | claimed |
| EP-3219316-A1 | MIXTURE OF FATTY ACIDS (F.A.G., FATTY ACIDS GROUP) FOR USE IN THE TREATMENT OF INFLAMMATORY PATHOLOGIES | Again Life Italia Srl (IT) | 2017-09-20 | — | — | EP | claimed |
| CN-102778528-B | Measuring method of content of pseudo-ceramide | SHANGHAI OLI ENTPR CO LTD | 2014-12-24 | — | — | CN | claimed |
| EP-1399112-B1 | Compositions comprising a cationic homopolymer and their use for stabilization of an oxidizing solution | OREAL (FR) | 2012-12-26 | — | — | EP | claimed |
| CN-102778528-A | Measuring method of content of pseudo-ceramide | SHANGHAI OLI ENTPR CO LTD | 2012-11-14 | — | — | CN | claimed |
| EP-1891925-A1 | Oily cosmetic composition in aerosol form | L'Oréal (FR) | 2008-02-27 | — | — | EP | claimed |
| US-20080031908-A1 | OILY COSMETIC COMPOSITION IN AEROSOL FORM | L'OREAL (FR) | 2008-02-07 | — | — | US | claimed |
| US-7204855-B2 | Compositions comprising a cationic homopolymer and their use for stabilization of an oxidizing solution | L'OREAL S.A. (FR) | 2007-04-17 | — | — | US | claimed |
| EP-1399112-A2 | COMPOSITIONS COMPRISING A CATIONIC HOMOPOLYMER AND THEIR USE FOR STABILIZATION OF AN OXIDIZING SOLUTION | L'OREAL S.A. (FR) | 2004-03-24 | — | — | EP | claimed |
| US-20030009834-A1 | Compositions comprising a cationic homopolymer and their use for stabilization of an oxidizing solution | L'OREAL S.A. (FR) | 2003-01-16 | — | — | US | claimed |
| WO-2002102351-A2 | COMPOSITIONS COMPRISING A CATIONIC HOMOPOLYMER AND THEIR USE FOR STABILIZATION OF AN OXIDIZING SOLUTION | L'OREAL S.A. (FR) | 2002-12-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030009834-A1 | Compositions comprising a cationic homopolymer and their use for stabilization of an oxidizing solution | KRT18, OAT, ADH1C | GPR84 3137/4885SPHK1 1834/4885FFAR1 411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.